Pathway,Score
Signaling by VEGF,-0.001471336444766457
Negative regulation of the PI3K/AKT network,-0.0007055016400039831
PI3K/AKT Signaling in Cancer,0.1386679641243665
G beta:gamma signalling through PI3Kgamma,0.0536968145636865
G-protein beta:gamma signalling,-0.01231053409032499
VEGFA-VEGFR2 Pathway,-0.01021004230354797
VEGFR2 mediated vascular permeability,0.0002855802610413975
Constitutive Signaling by AKT1 E17K in Cancer,0.054853589003787145
Respiratory Syncytial Virus Infection Pathway,0.0798062626330547
RSV-host interactions,0.025892486059042333
RHO GTPases Activate WASPs and WAVEs,-0.016610669084668146
RAC2 GTPase cycle,0.04006538647247179
RAC3 GTPase cycle,-0.03206037332001754
Parasite infection,0.2100134430663613
Leishmania phagocytosis,-0.004216335052541861
FCGR3A-mediated phagocytosis,-0.01066297427541207
Signaling by NOTCH1,-0.006360682689642952
NOTCH1 Intracellular Domain Regulates Transcription,-0.005672334399746013
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.00884443558331193
Signaling by NOTCH1 in Cancer,0.00875901825331405
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.01230884925334078
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.010744881718621842
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,-0.011175643510303805
Regulation of PTEN gene transcription,0.051437242910675876
Budding and maturation of HIV virion,0.1227641267304396
Uptake and actions of bacterial toxins,0.011277698126463155
Bacterial Infection Pathways,-0.05672089918141357
NRAGE signals death through JNK,-0.04253904689141575
p75 NTR receptor-mediated signalling,-0.040207512527350366
"Cell death signalling via NRAGE, NRIF and NADE",0.044187332992885
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,-0.0016075423292233305
Neurodegenerative Diseases,0.017865741101659026
Diseases of programmed cell death,0.09603851173129518
Defective Intrinsic Pathway for Apoptosis,-0.0326631566714846
Signaling by SCF-KIT,0.0018524990822945794
Regulation of KIT signaling,0.029696763123270756
Degradation of beta-catenin by the destruction complex,-0.030643970808162634
Beta-catenin phosphorylation cascade,0.010539771952883166
Disassembly of the destruction complex and recruitment of AXIN to the membrane,5.829343884744052e-06
G alpha (12/13) signalling events,0.0994247936439098
Pre-NOTCH Transcription and Translation,-0.014784051487181244
Pre-NOTCH Expression and Processing,-0.02719761011470291
Signaling by NOTCH2,-0.0027670478164809205
NOTCH2 intracellular domain regulates transcription,-0.00262772121846866
Signaling by NOTCH3,0.024679027687314167
NOTCH3 Intracellular Domain Regulates Transcription,-0.008579570104568127
Signaling by NOTCH4,-0.0013346927406469268
NOTCH4 Intracellular Domain Regulates Transcription,-0.03238160711178987
Signaling by MET,0.04203303163217824
RAS processing,0.051483536409061496
Potential therapeutics for SARS,-0.05053468389537225
Host Interactions of HIV factors,-0.010721767093016702
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.0538368362901925
The role of Nef in HIV-1 replication and disease pathogenesis,0.0006498791172528118
NR1H2 and NR1H3-mediated signaling,-0.017778602165301603
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.020492280930384944
Diseases of glycosylation,0.034584713211947414
Diseases associated with O-glycosylation of proteins,0.0076477547995753735
Defective GALNT3 causes HFTC,-0.018151996122864014
Defective GALNT12 causes CRCS1,0.015638087239950846
Diseases of metabolism,0.023735260196293347
Diseases of DNA repair,0.09348068006133269
Diseases of DNA Double-Strand Break Repair,-0.004765374066425312
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-8.26179685972211e-05
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,-0.002740671832056121
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.001977171577904286
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,-0.013157332757230682
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,-0.0007046413664930388
Impaired BRCA2 binding to RAD51,0.02852180735702089
Impaired BRCA2 binding to PALB2,0.06158575143249103
Effects of PIP2 hydrolysis,-0.045753000765974626
Integrin signaling,0.007808655916177229
Retrograde neurotrophin signalling,-0.003916468332862195
Signaling by NTRK1 (TRKA),-0.1229891432031122
TNFR1-induced proapoptotic signaling,0.001369891757677391
Regulation of TNFR1 signaling,-0.05613808621214617
TNFR1-induced NF-kappa-B signaling pathway,0.11999702720114636
TNF signaling,0.0012529265021207128
RHOA GTPase cycle,0.0035199313400113407
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.03036576091233728
HCMV Infection,-0.0003531585152520869
HCMV Early Events,-0.030937013102249278
Regulation of RAS by GAPs,-0.1512225243196028
RHOF GTPase cycle,-0.0036664084662605696
P2Y receptors,-0.007682091702951605
Nucleotide-like (purinergic) receptors,-0.0005290565737248577
Signaling by PTK6,-0.0549693882307886
Signaling by Non-Receptor Tyrosine Kinases,0.00840635626770466
Signaling by Retinoic Acid,-0.014509908867038079
RA biosynthesis pathway,-0.005193962578876377
Signaling by ERBB2,-0.006810454022029031
Downregulation of ERBB2 signaling,0.01665891996431187
Activated NOTCH1 Transmits Signal to the Nucleus,0.00713218049326247
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.20855110870099322
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.016250469986376033
Opioid Signalling,-0.019148802388652224
DARPP-32 events,0.03246527883198039
Nuclear Events (kinase and transcription factor activation),-0.021255272203829133
Signaling by NTRK2 (TRKB),-0.006873238197060537
NGF-stimulated transcription,-0.0073392012524225005
Class B/2 (Secretin family receptors),0.058891151699436296
G alpha (s) signalling events,-0.09809869464429054
RHOB GTPase cycle,0.004186619171043821
RHOC GTPase cycle,-0.03592955222525659
Vpu mediated degradation of CD4,0.004557266422164537
Vif-mediated degradation of APOBEC3G,-0.05031128898794358
PCP/CE pathway,-0.07546896376555375
Asymmetric localization of PCP proteins,0.0319133095585841
Degradation of AXIN,0.0349032882588964
Degradation of DVL,-0.00985859957217441
Hedgehog ligand biogenesis,-0.03172952524257816
Hh mutants are degraded by ERAD,-0.028163406422957414
Hh mutants abrogate ligand secretion,0.02012059651654262
Degradation of GLI1 by the proteasome,-0.00246458921130644
Degradation of GLI2 by the proteasome,-0.006287803826730979
GLI3 is processed to GLI3R by the proteasome,-0.010298530411782778
Hedgehog 'off' state,-0.020122251911998106
ABC transporter disorders,-0.0013360054819309285
Disorders of transmembrane transporters,6.6359167178804525e-06
Hedgehog 'on' state,0.0270144822956099
Defective CFTR causes cystic fibrosis,0.07070877942780177
MAPK6/MAPK4 signaling,0.013905274214058507
Regulation of PTEN stability and activity,-0.03041299426524961
Negative regulation of NOTCH4 signaling,-0.00300108932107227
Formation of HIV elongation complex in the absence of HIV Tat,-0.029581580417159442
Formation of the HIV-1 Early Elongation Complex,-0.00642002881181963
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.0001723585045042407
HIV Transcription Initiation,0.002284148854926131
RNA Polymerase II HIV Promoter Escape,-0.029912204316133492
HIV Transcription Elongation,-0.07973863879283055
Transcription of the HIV genome,0.025985482396416584
Formation of HIV-1 elongation complex containing HIV-1 Tat,-0.0039216788261214565
Tat-mediated elongation of the HIV-1 transcript,-0.013501041825710495
RHOBTB3 ATPase cycle,0.018632099987540045
Signaling by TGF-beta Receptor Complex,0.06008007784201698
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.015614465818452494
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.0069691366853989675
Pausing and recovery of Tat-mediated HIV elongation,-0.0031051387698323497
Tat-mediated HIV elongation arrest and recovery,-0.004732537811181971
HIV elongation arrest and recovery,0.01945499513904617
Pausing and recovery of HIV elongation,-0.05309033519180482
Estrogen-dependent gene expression,-0.015594124071494637
RHOBTB2 GTPase cycle,0.051533350998737716
RHOBTB1 GTPase cycle,0.023490231707165042
RHOBTB GTPase Cycle,-0.004680494727112416
Signaling by EGFR,0.00494908237989897
EGFR downregulation,-0.0006663937624745777
Signaling by FGFR,0.07304196764143414
Negative regulation of FGFR1 signaling,-0.0025818034109638902
Negative regulation of FGFR2 signaling,0.01283951036672019
Negative regulation of FGFR3 signaling,-0.0073578584037594
Negative regulation of FGFR4 signaling,0.03558581651538188
Signaling by FGFR1,0.04120378861947259
Signaling by FGFR2,0.005996639632155011
Signaling by FGFR3,-0.00210821156092192
Signaling by FGFR4,0.03809933520348936
Negative regulation of MET activity,-0.007058581281995891
InlB-mediated entry of Listeria monocytogenes into host cell,0.02536921781615324
Listeria monocytogenes entry into host cells,0.00023897771411033507
RHOU GTPase cycle,0.007675879370246229
MAP2K and MAPK activation,0.020488639648005312
Signaling by moderate kinase activity BRAF mutants,0.0390471700285226
Signaling by high-kinase activity BRAF mutants,0.01355904870881713
Signaling by RAS mutants,-0.00014222802283785104
Signaling by BRAF and RAF1 fusions,-0.03962141211478478
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.0009120208627248444
Oncogenic MAPK signaling,-0.013935427111896506
Signaling downstream of RAS mutants,0.010707160063502096
Signaling by RAF1 mutants,0.05607718267755284
AKT phosphorylates targets in the cytosol,-0.02544661637872635
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,-0.0007499995423554216
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.03058845501715591
Diseases of mitotic cell cycle,-0.005814959643382636
FLT3 signaling in disease,-0.001989183976561891
Aberrant regulation of mitotic cell cycle due to RB1 defects,0.006470928510686703
Signaling by ALK in cancer,-0.025122579051194947
Signaling by FLT3 ITD and TKD mutants,0.003956364687819579
Signaling by ALK fusions and activated point mutants,-0.004769708500344752
RHO GTPases activate CIT,0.04473912680383811
Extra-nuclear estrogen signaling,-0.011537702974921477
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,0.0023018929140491014
Signaling by Activin,0.006569767841732888
Downregulation of TGF-beta receptor signaling,-0.012671664115623557
TGF-beta receptor signaling activates SMADs,0.05808513562340189
G alpha (z) signalling events,-0.011059648638368719
Activation of RAC1,-0.0012181259973805504
RHOQ GTPase cycle,-0.027042157263698765
RHOH GTPase cycle,-0.016610980090166722
RHOG GTPase cycle,0.006856502863880004
RHOJ GTPase cycle,0.20876997562345623
RHOV GTPase cycle,-0.016370868490641056
Signaling by Insulin receptor,0.025416697376247483
Insulin receptor recycling,0.07610147271156628
MET activates PTK2 signaling,0.0012855875417630276
MET promotes cell motility,-0.059228289959216265
MTOR signalling,0.007173930540347077
mTORC1-mediated signalling,-0.00028571011490302216
Energy dependent regulation of mTOR by LKB1-AMPK,0.0031941287167819646
Diseases of Immune System,0.02699657679496047
Diseases associated with the TLR signaling cascade,-0.0037363440699273703
RHO GTPases activate IQGAPs,-0.02702292537215553
RHO GTPases Activate Formins,0.0532324239288932
RHO GTPases activate PKNs,-0.039955245130540086
RHO GTPases Activate ROCKs,-0.0003524153589409736
RHO GTPases activate PAKs,-0.0071277070226788315
Aberrant regulation of mitotic exit in cancer due to RB1 defects,0.03948195085129043
Pre-NOTCH Processing in Golgi,0.013226782694351423
Signaling by ERBB4,-0.011315953322707847
Nuclear signaling by ERBB4,-0.0017160936871928334
Signaling by Hippo,0.019114664768199622
RHOD GTPase cycle,0.015280833370947908
SARS-CoV-1-host interactions,-0.016448699027623276
SARS-CoV-1 activates/modulates innate immune responses,-0.010199006558748386
RND3 GTPase cycle,0.03913352958007808
Nuclear events stimulated by ALK signaling in cancer,-0.013712090424165504
HCMV Late Events,-0.014855603325200457
Formation of the beta-catenin:TCF transactivating complex,0.06801905241617337
Peptide ligand-binding receptors,-0.015656724623225923
Chemokine receptors bind chemokines,0.0018683301371507982
Translation of Structural Proteins,-4.9476969956620026e-05
Maturation of spike protein,0.012143742058295857
Late SARS-CoV-2 Infection Events,-0.01523867422881428
Purinergic signaling in leishmaniasis infection,0.00045424363417455993
Cell recruitment (pro-inflammatory response),0.05749819686291693
CaMK IV-mediated phosphorylation of CREB,0.004409614468077969
Calmodulin induced events,-0.010395591392238267
Ca-dependent events,0.021745634414482334
CaM pathway,-0.027417044304948505
G-protein mediated events,0.005828495164553966
PLC beta mediated events,-0.020135926813257227
DAG and IP3 signaling,-0.0012922934675517125
G-protein activation,-0.004748189887085771
Ca2+ pathway,-0.10044519716661822
G beta:gamma signalling through PLC beta,-0.013932039409764304
Glucagon-type ligand receptors,0.19700639929394992
G beta:gamma signalling through BTK,-0.05003047203278386
G beta:gamma signalling through CDC42,-0.023330493165221174
GPER1 signaling,-0.006702492591896748
ADORA2B mediated anti-inflammatory cytokines production,-0.03006034906318079
Anti-inflammatory response favouring Leishmania parasite infection,-0.023315520656015727
Leishmania parasite growth and survival,-0.026987302449542734
PKA-mediated phosphorylation of CREB,-0.039400609811117676
PKA activation,0.022892252908123936
Adenylate cyclase activating pathway,0.004764812566741535
Adenylate cyclase inhibitory pathway,-0.0015576665012043225
FCGR3A-mediated IL10 synthesis,-0.030504425928148938
Signaling by ERBB2 in Cancer,0.002803598076636131
Constitutive Signaling by Aberrant PI3K in Cancer,0.019981825586841938
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.08795880039610345
Signaling by ERBB2 KD Mutants,-0.0026476662024505224
Signaling by ERBB2 TMD/JMD mutants,-0.0064752272035584375
RND2 GTPase cycle,0.006220651040648787
Signaling by TGFBR3,0.030469367637030502
Rev-mediated nuclear export of HIV RNA,-0.007786501106314501
Transport of Ribonucleoproteins into the Host Nucleus,-0.003673084361588567
Export of Viral Ribonucleoproteins from Nucleus,-0.018869889036314
NS1 Mediated Effects on Host Pathways,-0.003406515314333919
Viral Messenger RNA Synthesis,0.005445682963584619
NEP/NS2 Interacts with the Cellular Export Machinery,-0.021274366773433834
Interactions of Vpr with host cellular proteins,0.11005787685651376
Interactions of Rev with host cellular proteins,0.002882635996391259
Nuclear import of Rev protein,0.0017189243646510532
Vpr-mediated nuclear import of PICs,0.00044428233195452994
SLC transporter disorders,-0.06017864886463474
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),-0.012499037767814945
VEGFR2 mediated cell proliferation,-0.0028849053237828526
Eicosanoid ligand-binding receptors,-0.020796529440351465
RHO GTPases Activate NADPH Oxidases,-0.00178999777676145
Downstream signaling of activated FGFR1,-0.026689300240862083
FRS-mediated FGFR1 signaling,-0.009401233569149995
Downstream signaling of activated FGFR2,0.0018432758829182649
FRS-mediated FGFR2 signaling,-0.0016251602128715822
FRS-mediated FGFR3 signaling,-0.006021144251324643
Downstream signaling of activated FGFR3,0.00035309609056027603
FRS-mediated FGFR4 signaling,-0.041022134267741574
Downstream signaling of activated FGFR4,-0.010984801612269751
RND1 GTPase cycle,-0.08556760168585993
Signaling by FGFR in disease,-0.0003102883268666847
Prolonged ERK activation events,0.00403017228404955
Frs2-mediated activation,-0.0006259077458339944
Signalling to ERKs,-0.061368198891702176
Signaling by ALK,-0.01400058735669686
Signaling by FGFR2 in disease,0.0001347707064124766
Signaling by FGFR1 in disease,-0.033180841227428495
Signaling by FGFR3 in disease,0.004765538971029307
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,-0.0025723958471295396
Activation of SMO,-0.001673448258875889
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.025543145017241146
Signaling by EGFR in Cancer,-0.0035284610997012625
Constitutive Signaling by EGFRvIII,-0.0035715161657775846
Signaling by EGFRvIII in Cancer,0.026537646260700806
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.017267081939976375
Signaling by ERBB2 ECD mutants,0.005457619513605423
Infection with Mycobacterium tuberculosis,-0.0014754694783942156
Response of Mtb to phagocytosis,-0.004583709490091547
Signaling by BMP,-0.006459460349923584
Early Phase of HIV Life Cycle,-0.002548635885421874
SARS-CoV-2 modulates host translation machinery,-0.011279045191700088
RAF-independent MAPK1/3 activation,-0.0119220824202495
Negative regulation of MAPK pathway,0.015630387469140444
Viral mRNA Translation,-0.01574005372261013
Amine ligand-binding receptors,-0.021741075308333524
Neurotoxicity of clostridium toxins,0.031389634982151485
SARS-CoV-2 modulates autophagy,-0.002164122085447613
PI3K Cascade,-0.0019898268891273426
IRS-mediated signalling,-0.04229713331271656
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.04723416855819085
IGF1R signaling cascade,-0.03943561799068907
IRS-related events triggered by IGF1R,-0.013761778417012769
Insulin receptor signalling cascade,-0.01616635052435037
WNT5A-dependent internalization of FZD4,0.03200281997082465
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",-0.0537680735980872
Induction of Cell-Cell Fusion,-0.005929435033614584
Signaling by PDGF,0.017023043152727756
Translation of Replicase and Assembly of the Replication Transcription Complex,0.0377136584287671
Early SARS-CoV-2 Infection Events,0.015149003249950155
Assembly Of The HIV Virion,-0.04620567625622842
Evasion by RSV of host interferon responses,0.008943496131615835
Downstream signal transduction,0.004151398333971537
p130Cas linkage to MAPK signaling for integrins,-0.01590505279979924
Signaling by Erythropoietin,0.04150301082377787
SARS-CoV-1 modulates host translation machinery,0.010837407039646125
Downregulation of SMAD2/3:SMAD4 transcriptional activity,0.003214503219060857
Maturation of nucleoprotein,0.019992532075599007
Signalling to RAS,0.021467736783291676
FGFR2 ligand binding and activation,-0.007949328561076469
Signaling by WNT in cancer,-0.023007978720675767
Signaling by AXIN mutants,0.07478398182926073
Signaling by CTNNB1 phospho-site mutants,-0.008042563065274228
Signaling by APC mutants,0.0010775022075960605
Signaling by AMER1 mutants,0.008735064610004279
Signaling by GSK3beta mutants,-0.010784789149750009
CTNNB1 S33 mutants aren't phosphorylated,-0.019382824467942334
CTNNB1 S37 mutants aren't phosphorylated,0.11832315291045246
CTNNB1 S45 mutants aren't phosphorylated,-0.0003279544099163234
CTNNB1 T41 mutants aren't phosphorylated,0.031737017516099975
APC truncation mutants have impaired AXIN binding,-0.010512957673059369
AXIN missense mutants destabilize the destruction complex,-0.029979217646326613
Truncations of AMER1 destabilize the destruction complex,-0.0022700125877132553
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",-8.16972916732035e-06
Maturation of hRSV A proteins,-1.830779398933363e-06
RHO GTPases activate KTN1,-0.007323263124472193
Deactivation of the beta-catenin transactivating complex,0.0016413543410062352
Repression of WNT target genes,0.022234829866955654
FGFR4 ligand binding and activation,-0.0013623263330478845
Phospholipase C-mediated cascade; FGFR4,0.019256774392401477
SHC-mediated cascade:FGFR4,0.03200465600361245
PI-3K cascade:FGFR4,0.03548987775032334
STAT3 nuclear events downstream of ALK signaling,0.008884833375514751
Defective pyroptosis,0.001289718303911742
ERK/MAPK targets,-0.026310625271900742
ERKs are inactivated,0.008662635972124695
TGFBR3 expression,-0.02242837141568398
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.013155742774193901
Class C/3 (Metabotropic glutamate/pheromone receptors),0.08970172316287103
FGFR1 mutant receptor activation,-0.005837065679907869
FGFR2 mutant receptor activation,0.01700901465206047
Activated point mutants of FGFR2,0.02169167029417217
Phospholipase C-mediated cascade; FGFR2,-0.009663415850714521
PI-3K cascade:FGFR1,-0.005144843755390352
PI-3K cascade:FGFR2,-0.029039904402347872
SHC-mediated cascade:FGFR2,0.0046081934665702885
Signaling by FGFR2 IIIa TM,0.00011012814443629444
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.005945684864991591
Abortive elongation of HIV-1 transcript in the absence of Tat,0.0034387325183319268
FGFR2 alternative splicing,-0.0057434674863802325
Regulation of PTEN mRNA translation,0.029026335056035104
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.029007435540711973
NRIF signals cell death from the nucleus,-0.0018092929141174596
Signaling by KIT in disease,-0.0023349356627280315
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.01944010823904131
Loss of function of MECP2 in Rett syndrome,0.0008209009638608178
Pervasive developmental disorders,-0.014292078872105542
Disorders of Developmental Biology,0.037926258645962774
Disorders of Nervous System Development,0.017877704194311207
Defects in vitamin and cofactor metabolism,-0.009669327108260727
Regulation of FZD by ubiquitination,-0.009498345249916208
Serotonin receptors,-0.0033971301860831254
p75NTR signals via NF-kB,0.04318223024011193
Signaling by NTRK3 (TRKC),-0.002240468831621931
RAF activation,-0.012959674756841778
p75NTR regulates axonogenesis,-0.012149356749501924
WNT ligand biogenesis and trafficking,-0.01823922858851347
